MARK J LEVIN
CIK 1180428 · last filed 2021-11-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$115.57M
Companies
14
Total Filings
89
Lifetime Open-Market Net
-$1.19B
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Jounce Therapeutics, Inc. (JNCE) Delisted | 10%+ Owner | 1,432,630 | $1.88 | $2.69M | -$197.76M | 2 | 2021-11-16 |
| FULC | Director | 84,223 | $3.45 | $290.6K | $1.30M | 5 | 2021-11-12 |
| RVMD | 10%+ Owner | 116,334 | $153.87 | $17.90M | -$349.03M | 3 | 2021-06-07 |
| VYGR | Director | 6,424,205 | $3.50 | $22.48M | $0 | 11 | 2021-06-04 |
| NRIX | 10%+ Owner | 3,500,667 | $16.95 | $59.34M | $0 | 1 | 2021-05-10 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | 10%+ Owner | 3,034,083 | $33.99 | $103.13M | $0 | 1 | 2018-08-24 |
| MyoKardia, Inc. (MYOK) Delisted | 10%+ Owner | 280,057 | — | — | $0 | 2 | 2018-03-07 |
| Global Blood Therapeutics, Inc. (GBT) Delisted | 10%+ Owner | 4,475,191 | $68.49 | $306.51M | -$470.21M | 4 | 2017-04-06 |
| CTMX | 10%+ Owner | 5,170,348 | $3.01 | $15.56M | -$172.20M | 2 | 2017-03-27 |
| Blueprint Medicines Corp (BPMC) Delisted | 10%+ Owner | 3,570,197 | $129.46 | $462.20M | -$1.23M | 1 | 2017-03-20 |
| Sage Therapeutics, Inc. (SAGE) Delisted | 10%+ Owner | 0 | $8.68 | $0 | $0 | 1 | 2015-01-28 |
| Carisma Therapeutics Inc. (EBIO) Delisted | Director | — | — | — | $0 | 1 | 2014-03-24 |
| Foundation Medicine, Inc. (FMI) Delisted | Director | 6,569,645 | — | — | $0 | 1 | 2013-10-02 |
| MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted | Director | 400,000 | — | — | -$4.69M | 54 | 2008-05-15 |
Recent Filings · Page 2 of 9
89 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-15 | FULC | Grant (A) | — | $0 | EDGAR |
| 2020-06-05 | VYGR | Grant (A) | — | $0 | EDGAR |
| 2019-07-22 | FULC | Mixed | +5,676,488 | $1.30M | EDGAR |
| 2019-06-17 | VYGR | Grant (A) | — | $0 | EDGAR |
| 2018-09-19 | VYGR | Other (J) | −1,500,000 | $0 | EDGAR |
| 2018-08-24 | CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Exer (X) | +255,160 | $395.5K | EDGAR |
| 2018-06-21 | VYGR | Other (J) | −1,500,000 | $0 | EDGAR |
| 2018-06-18 | VYGR | Grant (A) | — | $0 | EDGAR |
| 2018-03-07 | MyoKardia, Inc. (MYOK) Delisted | Other (J) | −10,000,000 | $0 | EDGAR |
| 2017-06-30 | VYGR | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.